News for 'otc'

RBI proposes easing forex transaction norms

RBI proposes easing forex transaction norms

Rediff.com3 days ago

The Reserve Bank on Tuesday proposed greater flexibility to authorised persons to undertake foreign exchange transactions for hedging their exposures, balance sheet management and market-making, as well as to ease reporting obligations, after a review of the current regulations.

Centre mandates blue strip on antimicrobial drugs to curb overuse

Centre mandates blue strip on antimicrobial drugs to curb overuse

Rediff.com24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.

Centre Proposes Stricter Cough Syrup Rules

Centre Proposes Stricter Cough Syrup Rules

Rediff.com1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in Madhya Pradesh three months ago, the Union health ministry has proposed amendments in the country's drug rules to ensure a tougher criterion for their over-the-counter (OTC) sales in India.

Duped of Rs 8 crore, ex-IPS officer attempts suicide

Duped of Rs 8 crore, ex-IPS officer attempts suicide

Rediff.com22 Dec 2025

Former IPS officer Amar Singh Chahal allegedly shot himself after claiming he was duped of Rs 8.10 crore by cyber thugs. He was one of the accused in the 2015 police firing cases related to anti-sacrilege protests in Faridkot.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Why the RSS was banned thrice in 100 years

Why the RSS was banned thrice in 100 years

Rediff.com1 Oct 2025

A timeline of key events that shaped the RSS' journey, including the various highs and lows, as the organization approaches its 100th anniversary.

GST rejig: Consumer stocks are top investment pick

GST rejig: Consumer stocks are top investment pick

Rediff.com19 Aug 2025

The proposed reforms in goods and services tax (GST) announced by the government last week, coupled with the eighth pay commission dole-out, is likely to push consumption-driven stocks - such as air conditioners (ACs), select automobiles, fast-moving consumer goods (FMCG), retail, and counters of quick-service restaurants (QSRs) - into higher orbit over the next few months, believe analysts.

Gold Prices Can Rise Up To 15% By December-End: WGC

Gold Prices Can Rise Up To 15% By December-End: WGC

Rediff.com17 Jul 2025

This translates into an annual return of 40 per cent, suggests a recent note by the World Gold Council.

Gold prices can rise 13% in 18 months to hit $3500 an ounce: BofA Securities

Gold prices can rise 13% in 18 months to hit $3500 an ounce: BofA Securities

Rediff.com2 Apr 2025

Gold prices could hit the $3500 an ounce (oz) mark in the next 18 months - up around 13 per cent from the current levels - given the global uncertainties and aided by investment demand, said analysts at BofA Securities in a recent note. Uncertainty around Trump Administration trade policies, BofA said, could continue to push the US dollar (USD) lower, further supporting gold prices near-term.

An insurer can now effectively manage market volatility

An insurer can now effectively manage market volatility

Rediff.com10 Mar 2025

The Insurance Regulatory and Development Authority of India's (Irdai's) decision to allow insurers to hedge risks through equity derivatives will help them manage market volatility and protect policyholder returns. However, this move is unlikely to alter their investment strategies.

Glenmark buys certain OTC drugs from Wockhardt in US

Glenmark buys certain OTC drugs from Wockhardt in US

Rediff.com28 Jun 2022

Glenmark Pharmaceuticals Ltd on Tuesday said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US. The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement. The company, however, did not disclose the financial details.

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Rediff.com8 Jul 2024

Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US. DRL will pay a total consideration of 500 million, including an upfront cash consideration of 458 million and contingent cash payments up to 42 million based on performances in CY25 and CY26. DRL will acquire the portfolio through the purchase of shares of Northstar Switzerland SARL, a Haleon group firm.

Rural markets drive FMCG sector; outpace urban areas

Rural markets drive FMCG sector; outpace urban areas

Rediff.com6 Feb 2025

The FMCG industry in India achieved a 10.6% growth in value terms in the December quarter of 2024, driven largely by rural markets, which have surpassed the large urban markets in growth for the fourth consecutive quarter. Festive demand and consumption-driven growth played a key role, with overall volume up 7.1% despite inflationary pressures. However, the industry also saw a "preference shift of consumers towards smaller packs" due to high food inflation. Local manufacturers continue to outperform larger FMCG companies, fueled by consistent volume growth.

Nandini Piramal gallops away in the OTC business

Nandini Piramal gallops away in the OTC business

Rediff.com13 Jul 2017

'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Rediff.com9 Aug 2024

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'

Is it time to start an OTC derivatives market?

Is it time to start an OTC derivatives market?

Rediff.com14 Nov 2007

Given how Participatory Notes are essentially an OTC market for Indian equity derivatives, moving them onshore should be an important objective.

India to be Reckitt's OTC production hub

India to be Reckitt's OTC production hub

Rediff.com30 Sep 2011

British consumer goods major Reckitt Benckiser, which bought over local start-up Paras Pharmaceuticals for a staggering Rs 3,260 crore (Rs 32.6 billion) last year, is converting its acquired Baddi plant in Himachal Pradesh into a global hub for manufacturing over-the-counter (OTC) pharmaceutical products.

Samvat 2081: Will Gold, Silver Sparkle?

Samvat 2081: Will Gold, Silver Sparkle?

Rediff.com25 Oct 2024

'Higher interest rates make gold less attractive as it doesn't generate yield.' 'However, with rates set to fall, the tables are turning for gold.'

FX derivatives mkt in a fix before new RBI rules

FX derivatives mkt in a fix before new RBI rules

Rediff.com11 Apr 2024

Exchange-traded currency derivatives volumes are likely to drop in view of new Reserve Bank of India (RBI) rules, casting a cloud over further participation of retail investors and proprietary traders. There are concerns that existing positions without any underlying exposure will need to be liquidated. Also, weighed down by dollar demand from local oil companies and weakness in its Asian peers, the rupee on Wednesday (April 3) ended at a new closing low of 83.44 versus the US currency.

Sebi's proposal on FPI dealings in corporate debt

Sebi's proposal on FPI dealings in corporate debt

Rediff.com14 Jul 2023

The Securities and Exchange Board of India (Sebi) has proposed that at least 10 per cent of corporate bond market trades by foreign portfolio investors (FPIs) should be done on the request for quote (RFQ) platform. At present, most trades in the corporate bond market are over-the-counter (OTC), creating a lot of opacity. The markets regulator has been nudging debt market participants such as mutual funds (MFs), alternative investment funds (AIFs) and brokers to use the RFQ platform to boost secondary market liquidity and transparency.

Q3FY24 earnings preview: Consumer business to boost RIL's earnings

Q3FY24 earnings preview: Consumer business to boost RIL's earnings

Rediff.com23 Jan 2024

Reliance Industries' (RIL's) consumer business is expected to lead earnings growth in the Q3FY24 performance, according to analysts. While the energy business is expected to show sequential weakness, the consumer business, especially retail, is estimated to show strong growth. The oil-to-telecom conglomerate will announce its Q3FY24 financial results on Friday.

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Rediff.com20 Nov 2023

Pharmaceuticals major Mankind Pharma reported a 21 per cent year-on-year (Y-o-Y) increase in net profit, with revenue rising by 12 per cent Y-o-Y in the second quarter of the financial year 2024 (Q2FY24) in a regulatory filing lrecently.

Zutshi Foundation to fight OTC drugs

Zutshi Foundation to fight OTC drugs

Rediff.com25 Jun 2008

A personal tragedy for Jeevan Zutshi, founder of the Indo-American Community Federation, turned into a talking point for the Unity Dinner '08 held at the Newark Fremont Hilton in California.

Chawanprash top ayurvedic OTC product in India

Chawanprash top ayurvedic OTC product in India

Rediff.com5 Apr 2010

Chawanprash, known for its medicinal quality and immunity enhancing capabilities, is the highest selling ayurvedic medicinal over-the-counter product in the country, according to a study.

Emami plans OTC foray in Pakistan

Emami plans OTC foray in Pakistan

Rediff.com23 Mar 2004

Does Protein Powder Harm Kidneys?

Does Protein Powder Harm Kidneys?

Rediff.com18 Mar 2023

'Digesting protein is hard work for the metabolic system. The more natural the protein is, the easier it is to digest,' explains Dr Karthiyayani Mahadevan.

How start-ups are shaking up offline pharma business

How start-ups are shaking up offline pharma business

Rediff.com3 Aug 2022

Bulk of the medicine sales in the $22-24 billion domestic pharma market happens through offline retail chemists. With the entry of online pharmacies, this space has started to witness a shake-up. Sample this: Dawaa Dost, a Rajasthan based digital health start-up, generates medicine orders from 'kirana' stores and women self-help groups (SHGs) that operate in villages, and then service these orders through its affiliated network of pharmacies. Biddano, another health-tech start-up, has a platform that acts as an aggregator for neighbourhood chemist shops.

How To Shop Smartly

How To Shop Smartly

Rediff.com27 Jan 2023

During a sale, many store windows invite the shopper with impossible-to-miss visuals announcing '50% Discount'. Only upon entering does the shopper realises that the one rack which fulfils this promise sells items she'd never purchase.

Novartis extends OTC R&D to India

Novartis extends OTC R&D to India

Rediff.com23 Feb 2006

The centre is expected to enhance our existing in-house research and development resources.

Global gold demand rises 28% to 1,181.5 tonnes in Q2

Global gold demand rises 28% to 1,181.5 tonnes in Q2

Rediff.com1 Nov 2022

Retail investment demand for gold bars and coins as well as central bank purchases pushed the global gold demand by 28 per cent to 1,181.5 tonnes in the September quarter, according to the World Gold Council report. The total global demand stood at 921.9 tonnes during the July-September quarter of 2021, the World Gold Council's 'Gold Demand Trends Q3 2022' showed on Tuesday. Investment was down 47 per cent year-on-year as gold backed Exchange Traded Fund (ETF) investors responded to a challenging combination of higher interest rates and a strong US dollar with significant outflows of 227 tonnes.

Govt gets cold feet on OTC drugs policy

Govt gets cold feet on OTC drugs policy

Rediff.com23 Dec 2006

Pharma companies' hope to have several of their house hold remedy brands like Crocin made available through grocery shops across the country may not materialise.

Keen to invest in unlisted shares? Read this

Keen to invest in unlisted shares? Read this

Rediff.com28 Apr 2021

Investing in unlisted shares is not difficult. At any given point, many investors and employees are willing to sell their holdings because they need money. Buyers can negotiate a price with them, suggests Sarbajeet K Sen.

From Lux to Kissan jam, Hindustan Unilever hikes prices by 3-13%

From Lux to Kissan jam, Hindustan Unilever hikes prices by 3-13%

Rediff.com2 Mar 2022

Hindustan Unilever (HUL) hiked prices across its portfolio of products by 3-13 per cent in multiple tranches in February, with the sharpest increase of 13 per cent seen in the 100 gm Lux soap pack, the price of which increased to Rs 35 from Rs 31 earlier. The price of the 125 gms soap pack of Lifebuoy was hiked from Rs 31 to Rs 33, a rise of 6.5 per cent. In January, the company had hiked the price of the same stock-keeping unit from Rs 29 to Rs 31.

Post SC ruling, Piramal readies big plans for Saridon

Post SC ruling, Piramal readies big plans for Saridon

Rediff.com21 Feb 2019

This ruling means that we will continue to invest in the brand and we will also look at launching line extensions over the next calendar year, said Nandini Piramal.

Cipla working on multiple therapies to fight spread of COVID

Cipla working on multiple therapies to fight spread of COVID

Rediff.com18 May 2020

Cipla is among the three Indian companies that signed a non-exclusive licensing agreement with US-based Gilead Sciences to make and distribute the latter's repurposed Ebola drug Remdesivir in 127 countries including India.

Govt has ambitious plans for the GIFT City

Govt has ambitious plans for the GIFT City

Rediff.com1 Feb 2022

The government on Tuesday said it will allow setting up of world-class foreign universities in Gandhinagar's GIFT City, free from domestic regulations, to facilitate availability of skilled manpower in the financial services space. In addition, an international arbitration centre will be set up in the GIFT City for timely settlement of disputes under international jurisprudence, Finance Minister Nirmala Sitharaman said while presenting the Union Budget for 2022-23. The centre could be on the lines of the Singapore International Arbitration Centre, or the London Commercial Arbitration Centre.

'We want licences for a few OTC drugs in India'

'We want licences for a few OTC drugs in India'

Rediff.com10 Sep 2009

About to touch Rs 1,000 crore (Rs 10 billion), India ranks among the eight most important countries in Reckitt Benckiser's global operations with sales in excess of 7 billion pounds (over Rs 55,000 crore). In an interaction with Pradipta Mukherjee, Reckitt Benckiser's India chairman and managing director Chander M Seithi reveals that plans are afoot to introduce most of its global brands in personal-care, home-care and over-the-counter drugs in India.

Want to use Retinoids for your skin problems? Read this

Want to use Retinoids for your skin problems? Read this

Rediff.com2 Jul 2018

Retinoids can cure skin issues, but they can harm too, says Dr Syed Nazim Hussain.

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Rediff.com19 Aug 2020

Reliance Retail Ventures Ltd has acquired a majority equity stake in digital pharma market place Netmeds for a cash consideration of around Rs 620 crore, Reliance Industries said in a late night statement on Tuesday.